Atopic dermatitis, also known as atopic eczema, affects close to 20 percent of children and adults in their lifetimes, with varied levels of duration and severity. Today’s clinical trials strive to develop education and treatment options for managing common skin disorders and rare diseases, but these studies are not without their challenges:
- Exclusion criteria and other barriers to enrolling patients.
- Regulatory and recruitment procedures for international trials across multiple sites.
- Patient participation and adherence to treatment over the short/long-term goals of the trial.
Clinical trial guidance, from startup to completion
Biorasi leverages our 15 years of experience in dermatology and skin health research to ensure effective and efficient management of clinical trials for atopic dermatitis. We work closely with our sponsors to achieve necessary recruitment results, and our strategy for decentralized trials offers remote solutions for conducting successful trials.
Biorasi Meets First Patient, First Visit Milestone for Dermatology Trial During COVID-19
How Dermatology Research Gaps Represent Untapped Markets for Pharmaceutical Companies
Patient Recruitment Challenges in Dermatology Clinical Trials